EOLS:NASDAQ, Evolus, Inc.

EOLS stock overview

Evolus, Inc. (EOLS:NASDAQ) closed at $6.81 on November 6, 2026, up 0.15% on the day. The stock trades 26.9% below its 52-week high of $9.31 and 76.3% above its 52-week low of $3.86. Over the past year, it gained 3.7%. Evolus, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$6.81
Day change
+0.15%
Volume
1,521,611
Average volume
878,521
Market cap
450M+
52-week range
$3.86 – $9.31
50-day average
$7.86
200-day average
$6.30

Price action over the past year

In 252 trading sessions since November 6, 2025, EOLS closed higher on 126 days (50%). Its best day was March 4, 2026 (+35.35%) and its worst was January 14, 2026 (-12.24%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

EOLS news

About Evolus, Inc.

Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex.

Similar stocks

Find more stocks like EOLS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.